Isaac Bentwich, M.D.

Founder & Global CEO, Corex

Dr. Isaac Bentwich is the Founder and Global CEO of CoreX, a world-leading BioAI company headquartered in Abu Dhabi that is redefining the frontiers of longevity and precision medicine. Under his leadership, CoreX has pioneered the world’s first national bio-intelligence engine, a transformative platform that integrates advanced artificial intelligence with "organ-on-chip" biological models.

The company’s mission is to move medicine beyond generic datasets by learning directly from human biology. Through a landmark partnership with the Institute for Healthier Living Abu Dhabi (IHLAD), Dr. Bentwich is leading the development of a predictive system built on the specific genetic and metabolic characteristics of the UAE population - positioning the Emirates as the first nation in the world to deploy such a sophisticated, human-centric medical infrastructure.

A physician, entrepreneur, and recognized figure in the longevity and healthspan ecosystem, Dr. Bentwich has spent his career at the intersection of artificial intelligence, genomics, and life sciences. He is deeply passionate about building interdisciplinary teams that translate advances in biology and machine learning into real-world impact, advancing medicine toward a more predictive and personalized future.

Previously, Dr. Bentwich founded Rosetta Genomics (NASDAQ: ROSG), where under his leadership the company analyzed the human genome, discovered hundreds of novel genes, and developed pioneering cancer diagnostics. A subsidiary, Rosetta Green (TASE: RSTG), was later acquired by Monsanto for $35 million.